ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)
JPY 2041.0
(-0.34%)
JPY 2041.0
(-0.34%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.4 Billion JPY | 15.35% |
| 2022 | 17.68 Billion JPY | 17.44% |
| 2021 | 15.06 Billion JPY | 4.79% |
| 2020 | 14.37 Billion JPY | 2.35% |
| 2019 | 14.04 Billion JPY | 0.26% |
| 2018 | 14 Billion JPY | 18.01% |
| 2017 | 11.86 Billion JPY | 11.09% |
| 2016 | 10.68 Billion JPY | -3.97% |
| 2015 | 11.12 Billion JPY | -2.2% |
| 2014 | 11.37 Billion JPY | 23.23% |
| 2013 | 9.23 Billion JPY | -3.53% |
| 2012 | 9.56 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 20.5 Billion JPY | 0.48% |
| 2024 Q2 | 20.72 Billion JPY | 1.11% |
| 2023 Q2 | 18.58 Billion JPY | 6.2% |
| 2023 FY | 20.4 Billion JPY | 15.35% |
| 2023 Q4 | 20.4 Billion JPY | 3.5% |
| 2023 Q3 | 19.71 Billion JPY | 6.06% |
| 2023 Q1 | 17.5 Billion JPY | -1.05% |
| 2022 Q3 | 17.64 Billion JPY | 9.23% |
| 2022 Q4 | 17.68 Billion JPY | 0.22% |
| 2022 FY | 17.68 Billion JPY | 17.44% |
| 2022 Q1 | 15.85 Billion JPY | 5.29% |
| 2022 Q2 | 16.15 Billion JPY | 1.89% |
| 2021 FY | 15.06 Billion JPY | 4.79% |
| 2021 Q3 | 14.41 Billion JPY | 5.66% |
| 2021 Q1 | 14.05 Billion JPY | -2.23% |
| 2021 Q4 | 15.06 Billion JPY | 4.49% |
| 2021 Q2 | 13.64 Billion JPY | -2.92% |
| 2020 Q2 | 14.38 Billion JPY | 3.3% |
| 2020 FY | 14.37 Billion JPY | 2.35% |
| 2020 Q4 | 14.37 Billion JPY | 4.35% |
| 2020 Q1 | 13.92 Billion JPY | -0.8% |
| 2020 Q3 | 13.77 Billion JPY | -4.27% |
| 2019 Q2 | 14.96 Billion JPY | -4.48% |
| 2019 Q3 | 13.58 Billion JPY | -9.25% |
| 2019 FY | 14.04 Billion JPY | 0.26% |
| 2019 Q1 | 15.67 Billion JPY | 11.89% |
| 2019 Q4 | 14.04 Billion JPY | 3.38% |
| 2018 Q4 | 14 Billion JPY | 22.22% |
| 2018 Q2 | 12.55 Billion JPY | 1.27% |
| 2018 Q1 | 12.39 Billion JPY | 4.46% |
| 2018 FY | 14 Billion JPY | 18.01% |
| 2018 Q3 | 11.45 Billion JPY | -8.72% |
| 2017 Q1 | 11.82 Billion JPY | 10.68% |
| 2017 FY | 11.86 Billion JPY | 11.09% |
| 2017 Q4 | 11.86 Billion JPY | -0.07% |
| 2017 Q3 | 11.87 Billion JPY | -0.25% |
| 2017 Q2 | 11.9 Billion JPY | 0.69% |
| 2016 Q1 | 11.14 Billion JPY | 0.18% |
| 2016 FY | 10.68 Billion JPY | -3.97% |
| 2016 Q2 | 10.43 Billion JPY | -6.4% |
| 2016 Q4 | 10.68 Billion JPY | 6.14% |
| 2016 Q3 | 10.06 Billion JPY | -3.52% |
| 2015 Q2 | 12.64 Billion JPY | 2.31% |
| 2015 Q1 | 12.36 Billion JPY | 8.68% |
| 2015 Q4 | 11.12 Billion JPY | -9.62% |
| 2015 Q3 | 12.3 Billion JPY | -2.67% |
| 2015 FY | 11.12 Billion JPY | -2.2% |
| 2014 Q4 | 11.37 Billion JPY | 24.15% |
| 2014 Q2 | 9.03 Billion JPY | -9.99% |
| 2014 Q1 | 10.03 Billion JPY | 8.68% |
| 2014 Q3 | 9.16 Billion JPY | 1.46% |
| 2014 FY | 11.37 Billion JPY | 23.23% |
| 2013 FY | 9.23 Billion JPY | -3.53% |
| 2013 Q1 | 9.98 Billion JPY | 4.36% |
| 2013 Q3 | 10.09 Billion JPY | -2.63% |
| 2013 Q4 | 9.23 Billion JPY | -8.51% |
| 2013 Q2 | 10.36 Billion JPY | 3.78% |
| 2012 Q4 | 9.56 Billion JPY | -5.3% |
| 2012 Q3 | 10.1 Billion JPY | -0.56% |
| 2012 Q2 | 10.16 Billion JPY | 0.0% |
| 2012 FY | 9.56 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -203.737% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 98.314% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 82.313% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 68.572% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -917.031% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 47.836% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | -18.844% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 88.318% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -540.565% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 3.655% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 32.618% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | -43.656% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -90.282% |
| Tsumura & Co. | 117.61 Billion JPY | 82.654% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 22.414% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | -89.927% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 79.814% |
| Fuji Pharma Co., Ltd. | 19.37 Billion JPY | -5.322% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | -40.803% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 61.844% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -945.184% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 2.336% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -8692.829% |
| MedRx Co., Ltd | 10 Million JPY | -203920.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -1177.834% |
| Solasia Pharma K.K. | 122 Million JPY | -16622.951% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -321039.619% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 79.598% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -44208.828% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 76.627% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -800.251% |